Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)
Clinical trial NCT03003962 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03003962
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-02
- Primary completion
- 2022-10-27
- Enrollment
- 669
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.